American Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.04M Buy
19,275
+385
+2% +$96.8K 0.22% 53
2025
Q4
$5.37M Sell
18,890
-140
-0.7% -$43.8K 0.24% 48
2025
Q3
$5.88M Buy
19,030
+1,715
+10% +$537K 0.23% 49
2025
Q2
$5.44M Buy
17,315
+415
+2% +$120K 0.23% 47
2025
Q1
$4.44M Buy
16,900
+2,100
+14% +$568K 0.18% 47
2024
Q4
$3.86M Hold
14,800
0.14% 48
2024
Q3
$3.44M Buy
14,800
+3,197
+28% +$656K 0.11% 49
2024
Q2
$2.34M Buy
11,603
+170
+1% +$30.6K 0.08% 53
2024
Q1
$1.96M Sell
11,433
-332
-3% -$61.9K 0.06% 53
2023
Q4
$2.55M Buy
+11,765
New +$2.02M 0.09% 54

Other funds holding PODD

American Capital Management's PODD Position: Q1 2026 in Review

American Capital Management increased its Insulet (PODD) stake by 2% in Q1 2026, buying an estimated $96.8K and bringing the position to 19,275 shares worth $4.04M. The position accounts for 0.22% of the portfolio, ranked #53.

American Capital Management first reported a position in PODD in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.88M in Q3 2025. 786 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • American Capital Management held 19,275 shares of Insulet worth $4.04M as of Q1 2026.
  • American Capital Management bought 385 Insulet shares in Q1 2026, an estimated $96.8K.
  • Insulet made up 0.22% of American Capital Management's portfolio in Q1 2026, its #53 holding.
  • American Capital Management first reported a position in Insulet in Q4 2023 and has held it in 10 quarters since.
  • American Capital Management's Insulet position peaked at $5.88M in Q3 2025.
  • 786 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on American Capital Management's 13F filing for Q1 2026, filed 15 May 2026.